Royal Medical Services Approves Caffeine Citrate from Al Razi Drug Store

In August 2026, the Royal Medical Services approved Caffeine Citrate 10 mg/mL from Al Razi Drug Store. The product is a solution for injection supplied in 1 mL ampoules and is used to treat apnoea of prematurity in neonatal intensive care units.